| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Mariantonia Ferrara, Alessandra Loda, Giulia Coco, Piergiacomo Grassi, Silvia Cestaro, Sara Rezzola, Vito Romano, Francesco Semerar. Diabetic Retinopathy: Soluble and Imaging Ocular Biomarkers. Journal of clinical medicine. vol 12. issue 3. 2023-02-11. PMID:36769560. |
diabetic retinopathy (dr), the most common microvascular complication of diabetes mellitus, represents the leading cause of acquired blindness in the working-age population. |
2023-02-11 |
2023-08-14 |
Not clear |
| Daria Stoia, Madalina Nistor, Maria Suciu, Raluca Borlan, Andreea Campu, Dumitrita Rugina, Dana Maniu, Simion Astilean, Monica Focsa. NIR photothermal-activable drug-conjugated microcapsules for in vitro targeted delivery and release: an alternative treatment of diabetic retinopathy. International journal of pharmaceutics. 2023-02-10. PMID:36764419. |
diabetic retinopathy (dr) is one of the most serious complications of diabetes, which leads to blindness. |
2023-02-10 |
2023-08-14 |
Not clear |
| Mark A Chia, Fred Hersch, Rory Sayres, Pinal Bavishi, Richa Tiwari, Pearse A Keane, Angus W Turne. Validation of a deep learning system for the detection of diabetic retinopathy in Indigenous Australians. The British journal of ophthalmology. 2023-02-06. PMID:36746615. |
this study evaluates the performance of a dls for dr detection among indigenous australians, an understudied ethnic group who suffer disproportionately from dr-related blindness. |
2023-02-06 |
2023-08-14 |
Not clear |
| S Ghouali, E M Onyema, M S Guellil, M A Wajid, O Clare, W Cherifi, M Feha. Artificial Intelligence-Based Teleopthalmology Application for Diagnosis of Diabetics Retinopathy. IEEE open journal of engineering in medicine and biology. vol 3. 2023-01-30. PMID:36712318. |
diabetic retinopathy (dr) is one of the leading causes of blindness for people who have diabetes in the world. |
2023-01-30 |
2023-08-14 |
Not clear |
| Jialin Cui, Enze Shi, Yingjie Wang, Tiantian Li. Network pharmacology study of the mechanism underlying the therapeutic effect of Zhujing pill and its main component oleanolic acid against diabetic retinopathy. Bioscience reports. vol 43. issue 1. 2023-01-30. PMID:36714956. |
diabetic retinopathy (dr) is the leading cause of blindness in the working population worldwide, with few effective drugs available for its treatment in the early stages. |
2023-01-30 |
2023-08-14 |
Not clear |
| Liling Chen, Ting Li, Fan Y. Circ_0006667 contributes to high glucose-induced retinal pigment epithelial cell dysfunction by mediating miR-7-5p/TGFA axis in diabetic retinopathy. International ophthalmology. 2023-01-30. PMID:36715959. |
diabetic retinopathy (dr) is a common complication of diabetes mellitus and it can lead to visual impairment and blindness. |
2023-01-30 |
2023-08-14 |
Not clear |
| Erfan Rezazadeh-Gavgani, Mobina Oladghaffari, Shirin Bahramian, Reza Majidazar, Sanam Dolat. MicroRNA-21: A critical underestimated molecule in Diabetic Retinopathy. Gene. 2023-01-23. PMID:36690226. |
diabetic retinopathy (dr) is a chronic microvascular complication of dm and is considered as the primary reason for blindness in adults. |
2023-01-23 |
2023-08-14 |
human |
| Krzysztof Gomułka, Michał Rut. The Role of Inflammation and Therapeutic Concepts in Diabetic Retinopathy-A Short Review. International journal of molecular sciences. vol 24. issue 2. 2023-01-21. PMID:36674535. |
diabetic retinopathy (dr) as a microangiopathy is the most common complication in patients with diabetes mellitus (dm) and remains the leading cause of blindness among adult population. |
2023-01-21 |
2023-08-14 |
Not clear |
| Suqian Wu, Xiaofen M. Optic Nerve Regeneration in Diabetic Retinopathy: Potentials and Challenges Ahead. International journal of molecular sciences. vol 24. issue 2. 2023-01-21. PMID:36674963. |
diabetic retinopathy (dr), the most common microvascular compilation of diabetes, is the leading cause of vision loss and blindness worldwide. |
2023-01-21 |
2023-08-14 |
Not clear |
| Jesus H Gonzalez-Cortes, Victor A Martinez-Pacheco, Jesus E Gonzalez-Cantu, Alper Bilgic, Francesc March de Ribot, Aditya Sudhalkar, Jesus Mohamed-Hamsho, Laurent Kodjikian, Thibaud Mathi. Current Treatments and Innovations in Diabetic Retinopathy and Diabetic Macular Edema. Pharmaceutics. vol 15. issue 1. 2023-01-21. PMID:36678750. |
diabetic retinopathy (dr) is one of the leading causes of blindness worldwide. |
2023-01-21 |
2023-08-14 |
Not clear |
| Ying Gao, Min Xue, Bing Dai, Yun Tang, Jingyu Liu, Changlin Zhao, Hu Meng, Feng Yan, Xiaomin Zhu, Yan Lu, Yirui G. Identification of immune associated potential molecular targets in proliferative diabetic retinopathy. BMC ophthalmology. vol 23. issue 1. 2023-01-19. PMID:36658547. |
diabetic retinopathy (dr) is one of the most common microvascular complications of diabetes and causes of blindness in developed countries. |
2023-01-19 |
2023-08-14 |
Not clear |
| Huixun Jia, Huihuan Luo, Zhenyu Wu, Xia Meng, Lina Zhang, Weiting Hu, Kexin Yu, Renjie Chen, Xiaodong Su. Residential greenness exposure and decreased prevalence of diabetic retinopathy: A nationwide analysis in China. Environmental research. 2023-01-15. PMID:36642124. |
diabetic retinopathy (dr) is a leading cause of vision impairment and blindness among diabetics. |
2023-01-15 |
2023-08-14 |
Not clear |
| Sheng Li, Gaoxiang Ouyang, Linhui Yuan, Xiaoxuan Wu, Lijun Zhan. SOX9 modulates Müller cell gliosis in diabetic retinopathy through upregulating TXNIP transcription. Experimental animals. 2023-01-15. PMID:36642539. |
diabetic retinopathy (dr), a common complication of diabetes, involves excessive proliferation and inflammation of muller cells and ultimately leads to vision loss and blindness. |
2023-01-15 |
2023-08-14 |
rat |
| Lakshini Y Herat, Jennifer R Matthews, Wei E Ong, Elizabeth P Rakoczy, Markus P Schlaich, Vance B Matthew. Determining the Role of SGLT2 Inhibition with Dapagliflozin in the Development of Diabetic Retinopathy. Frontiers in bioscience (Landmark edition). vol 27. issue 12. 2023-01-10. PMID:36624945. |
diabetic retinopathy (dr) is a major cause of blindness globally. |
2023-01-10 |
2023-08-14 |
mouse |
| Usharani Bhimavarapu, Gopi Battinen. Deep Learning for the Detection and Classification of Diabetic Retinopathy with an Improved Activation Function. Healthcare (Basel, Switzerland). vol 11. issue 1. 2023-01-08. PMID:36611557. |
diabetic retinopathy (dr) is an eye disease triggered due to diabetes, which may lead to blindness. |
2023-01-08 |
2023-08-14 |
Not clear |
| Koyo Takase, Harumasa Yokota, Akira Ohno, Masahisa Watanabe, Akifumi Kushiyama, Sakura Kushiyama, Satoru Yamagami, Taiji Nagaok. A pilot study of diabetic retinopathy in a porcine model of maturity onset diabetes of the young type 3 (MODY3). Experimental eye research. 2023-01-07. PMID:36608813. |
diabetic retinopathy (dr) is a leading cause of blindness in the working population. |
2023-01-07 |
2023-08-14 |
human |
| Zhengwei Yang, Tien-En Tan, Yan Shao, Tien Yin Wong, Xiaorong L. Classification of diabetic retinopathy: Past, present and future. Frontiers in endocrinology. vol 13. 2023-01-02. PMID:36589807. |
diabetic retinopathy (dr) is a leading cause of visual impairment and blindness worldwide. |
2023-01-02 |
2023-08-14 |
Not clear |
| Katie Curran, Prabhath Piyasena, Nathan Congdon, Lisa Duke, Belma Malanda, Tunde Pet. Inclusion of diabetic retinopathy screening strategies in national-level diabetes care planning in low- and middle-income countries: a scoping review. Health research policy and systems. vol 21. issue 1. 2023-01-02. PMID:36593508. |
diabetic retinopathy (dr) is one of the most common microvascular complications of diabetes, and early detection through diabetic eye screening programmes is essential to prevent visual impairment and blindness. |
2023-01-02 |
2023-08-14 |
Not clear |
| Haitao Yan, Jiexin Xie, Deliang Zhu, Lukuan Jia, Shijie Gu. MSLF-Net: A Multi-Scale and Multi-Level Feature Fusion Net for Diabetic Retinopathy Segmentation. Diagnostics (Basel, Switzerland). vol 12. issue 12. 2022-12-23. PMID:36552925. |
diabetic retinopathy (dr) is a diabetic complication that predisposes patients to visual impairments that could lead to blindness. |
2022-12-23 |
2023-08-14 |
Not clear |
| Mengxue Xia, Fang Zhan. Amino Acids Metabolism in Retinopathy: From Clinical and Basic Research Perspective. Metabolites. vol 12. issue 12. 2022-12-23. PMID:36557282. |
retinopathy, including age-related macular degeneration (amd), diabetic retinopathy (dr), and retinopathy of prematurity (rop), are the leading cause of blindness among seniors, working-age populations, and children. |
2022-12-23 |
2023-08-14 |
human |